SRRK
SRRK
NASDAQ · Biotechnology

Scholar Rock Holding Corp

$52.92
+0.28 (+0.53%)
As of Aug 7, 8:25 PM ET ·
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 23 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target +34.7% upside
Low Target $54.07
Average Target $71.29
High Target $91.55
Current Price $52.92
Current
$52.92
Target
$71.29
$54.07 $71.29 avg $91.55
Scenario Analysis
Bear Case
$54.07
2.2%
Low target
Base Case
$71.29
+34.7%
Avg target
Bull Case
$91.55
+73.0%
High target
Risk/Reward
33.6x
Highly favorable
Price in Context
52-Week High
$58.49
-9.5% from high
52-Week Low
$27.07
+95.5% from low
50-Day SMA
$45.16
+17.2% vs SMA
200-Day SMA
$36.91
+43.4% vs SMA
RSI (14)
59.5
Neutral
Target vs 52W High
$71.29
+21.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -43.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.3%
BIIB
Biogen Inc
Buy 44 64% $91.45 -55.7%